---
title: "Innovative drugs are sluggish, Hwabao WP Hang Seng SCHK Innovative Drug Select ETF (520880) hits a new historical low! AKESO and 3SBIO drop over 3%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/287568569.md"
description: "As of May 26, 2026, Hwabao WP Hang Seng SCHK Innovative Drug ETF (520880) fell by 1.57%, closing at CNY 0.438, hitting a historical low. This ETF closely tracks the Hang Seng SCHK Innovative Drug Select Index, with the latest size reaching CNY 2.697 billion and shares totaling 5.976 billion. In the past week, it attracted CNY 99.7502 million. Among the index constituents, AKESO and 3SBIO both fell by over 3%"
datetime: "2026-05-26T02:06:33.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/287568569.md)
  - [en](https://longbridge.com/en/news/287568569.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/287568569.md)
---

# Innovative drugs are sluggish, Hwabao WP Hang Seng SCHK Innovative Drug Select ETF (520880) hits a new historical low! AKESO and 3SBIO drop over 3%

As of May 26, 2026, 10:01, the Hwabao (520880) Hong Kong Stock Connect Innovative Drug ETF fell by 1.57%, with the latest price reported at 0.438 yuan and a turnover rate of 4.69%.

The Hwabao (520880) Hong Kong Stock Connect Innovative Drug ETF closely tracks the Hang Seng Hong Kong Stock Connect Innovative Drug Select Index. Among the index's weighted stocks, Zai Lab rose by 0.83%, Rongchang Bio fell by 2.3%, China Biologic Products fell by 2.02%, and Innovent Biologics fell by 1.91%. The index aims to reflect the performance of Hong Kong-listed companies that can be traded through the Hong Kong Stock Connect and are related to the research, development, and production of innovative drugs. Base date: December 31, 2020. Base point: 3000.

Data shows that the latest scale of the Hwabao (520880) Hong Kong Stock Connect Innovative Drug ETF reached 2.697 billion yuan, with the latest share count at 5.976 billion shares, an increase of 513 million yuan in fund size compared to a month ago.

As of the previous trading day, the Hwabao (520880) Hong Kong Stock Connect Innovative Drug ETF attracted a total of 99.7502 million yuan in the past week.

The Hwabao (520880) Hong Kong Stock Connect Innovative Drug ETF, off-exchange connections (025220.OF, 025221.OF)

### Related Stocks

- [01530.HK](https://longbridge.com/en/quote/01530.HK.md)
- [09926.HK](https://longbridge.com/en/quote/09926.HK.md)
- [520880.CN](https://longbridge.com/en/quote/520880.CN.md)
- [159316.CN](https://longbridge.com/en/quote/159316.CN.md)
- [09688.HK](https://longbridge.com/en/quote/09688.HK.md)
- [ZLAB.US](https://longbridge.com/en/quote/ZLAB.US.md)
- [09995.HK](https://longbridge.com/en/quote/09995.HK.md)
- [688331.CN](https://longbridge.com/en/quote/688331.CN.md)
- [01177.HK](https://longbridge.com/en/quote/01177.HK.md)
- [01801.HK](https://longbridge.com/en/quote/01801.HK.md)
- [688336.CN](https://longbridge.com/en/quote/688336.CN.md)

## Related News & Research

- [Franklin Templeton announces ETF cash distributions](https://longbridge.com/en/news/287538836.md)
- [Want Stability and Income? This Canadian Banking ETF Checks Both Boxes](https://longbridge.com/en/news/287931441.md)
- [Hedgeye Asset Management Launches ADDS, an Active ETF Designed to Target Companies Before They Enter Major Indexes | ADDS Stock News](https://longbridge.com/en/news/287935741.md)
- [Manulife Strategic Income Fund ETF Sr declares CAD 0.0342 dividend](https://longbridge.com/en/news/287544114.md)
- [Low-cost gold ETF launched as Hong Kong links bullion trading with blockchain](https://longbridge.com/en/news/287924299.md)